# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA658552 | F | Resistant factor, determined between IC50 of resistant line to that of CHcisR cell line | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
2. | ALA656586 | F | Growth inhibition against CH-1 wild-type ovarian cell lines | Homo sapiens | 22 | cell-based format | Scientific Literature | ||
3. | ALA656587 | F | Compound was evaluated for growth inhibition against CH1cisR wild-type ovarian cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
4. | ALA883497 | F | Growth inhibition against CH-1 cisplatin resistant wild-type ovarian cell lines | Homo sapiens | 20 | cell-based format | Scientific Literature | ||
5. | ALA656588 | F | Antitumor activity of compound for 96-h exposure in CH1 human ovarian cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
6. | ALA656589 | F | The compound was tested for cytotoxic activity against CH1 cell line(human ovarian carcinoma ) | 1 | cell-based format | Scientific Literature | |||
7. | ALA656590 | F | The compound was tested for cytotoxic activity against CH1 cell line(human ovarian carcinoma ) | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
8. | ALA656591 | F | In vitro cytotoxicity of compound was determined against CH1 (cisplatin resistant) cell lines at 37 degree C after 96 hr | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
9. | ALA656592 | F | In vitro cytotoxicity of compound was determined against CH1 (cisplatin resistant) cell lines at 37 degree C for 96 hr | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
10. | ALA657456 | F | In vitro cytotoxicity against human ovarian carcinoma cell line CH1 using sulforhodamine B (SRB) assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
11. | ALA657457 | F | Compound was evaluated for cytotoxicity against CH1 cell line | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
12. | ALA657458 | F | Concentration required to inhibit CH1 tumor cell growth when compared with control after incubation for 96 hr at 37 C | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
13. | ALA657459 | F | Antiproliferative activity in human ovarian cancer cell line (CH1) using MTT assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
14. | ALA657460 | F | Compound was evaluated against human Ovarian carcinoma cell line CH1 | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
15. | ALA657461 | F | Compound was tested for inhibitory activity against CH1cisR human ovarian carcinoma cell line; activity expressed in Mean IC50 values | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
16. | ALA657462 | F | Compound was tested for inhibitory activity against CH1 human ovarian carcinoma cell line; activity expressed in Mean IC50 values | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
17. | ALA657463 | F | In vitro inhibition of human ovarian cell line (CH1) | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
18. | ALA657464 | F | In vitro inhibition of human ovarian cell line, resistant to cisplatin (CH1cisR). | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
19. | ALA877292 | F | In vitro inhibition of human ovarian cell line, resistant to doxorubicin (CH1doxR). | Homo sapiens | 35 | cell-based format | Scientific Literature | ||
20. | ALA657465 | F | Cytotoxic activity in a panel of Human ovarian tumor CH1 cell line after 96h of drug exposure | Homo sapiens | 3 | cell-based format | Scientific Literature |